|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,340.50 JPY | -0.95% |
|
+8.41% | +11.83% |
| 10/08 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| 06/08 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| Market Cap | 4,237B 26.6B 23.05B 21.58B 19.69B 37.06B 2,537B 37.68B 253B 99.15B 1,270B 99.88B 97.71B | P/E 2027 * |
11.8x | P/E 2028 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 4,248B 26.67B 23.11B 21.64B 19.74B 37.15B 2,544B 37.78B 254B 99.41B 1,273B 100B 97.96B | EV / Sales 2027 * |
1.86x | EV / Sales 2028 * | 1.82x |
| Free-Float |
98.88% | Yield 2027 * |
3.4% | Yield 2028 * | 3.51% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -0.95% | ||
| 1 week | +8.41% | ||
| Current month | +6.29% | ||
| 1 month | +10.35% | ||
| 3 months | +0.54% | ||
| 6 months | -5.24% | ||
| Current year | +11.83% |
| 1 week | 2,168 |  | 2,377 |
| 1 month | 2,109 | | 2,377 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | +8.41% | +41.93% | +5.24% | 26.6B | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 363B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 295B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | -0.37% | +1,722.69% | +35.00% | +41.12% | 368.57B | |
| Weighted average by Cap. | -0.62% | +1,339.32% | +49.58% | +65.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,288B 14.37B 12.45B 11.66B 10.64B 20.02B 1,370B 20.35B 137B 53.55B 686B 53.95B 52.77B | 2,101B 13.19B 11.43B 10.7B 9.77B 18.38B 1,258B 18.68B 125B 49.17B 630B 49.53B 48.45B |
| Net income | 343B 2.16B 1.87B 1.75B 1.6B 3B 206B 3.05B 20.51B 8.04B 103B 8.1B 7.92B | 324B 2.03B 1.76B 1.65B 1.51B 2.83B 194B 2.88B 19.35B 7.58B 97.12B 7.64B 7.47B |
| Net Debt | 11.12B 69.84M 60.52M 56.66M 51.7M 97.28M 6.66B 98.92M 664M 260M 3.33B 262M 257M | -418B -2.62B -2.27B -2.13B -1.94B -3.65B -250B -3.71B -24.95B -9.78B -125B -9.85B -9.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | JPY 2,340.50 | -0.95% | 3,193,700 |
| 10/08/26 | JPY 2,363.00 | +1.55% | 6,287,500 |
| 07/08/26 | JPY 2,327.00 | +1.68% | 8,001,800 |
| 06/08/26 | JPY 2,288.50 | +6.00% | 10,352,900 |
| 05/08/26 | JPY 2,159.00 | -0.44% | 5,388,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
